22nd Century Signs Testing Services Agreement with North Carolina State University
22nd Century announced corporate updates regarding a new testing services agreement with North Carolina State University aimed at validating tobacco varieties featuring improved leaf quality and increased crop yields with the same low-nicotine content. The initiative builds upon 22nd Century's reduced nicotine content technology platform, which utilizes plant breeding and biotechnology to reduce nicotine content in tobacco to minimally addictive levels. The company's reduced nicotine tobacco is the foundation of its FDA-authorized VLN combustible cigarette products. The newly signed testing services agreement will focus on confirming commercial viability of tobacco varieties incorporating 22nd Century's patented low-nicotine genetics to increase yield, improve leaf quality and consistency, support more efficient, scalable production, ensure long-term sustainability for contracted growers, and preserve the integrity of the company's reduced-nicotine characteristics. Under the terms of the testing services agreement, researchers at North Carolina State University will work alongside 22nd Century's plant science team to evaluate genetic pathways associated with increased harvest volume per acre and an even better-quality leaf for our new lines of reduced nicotine tobacco. The research is expected to include field evaluations, quality assessments, yield calculations, and alkaloid characterization with nicotine quantification.
Trade with 70% Backtested Accuracy
Analyst Views on XXII
About XXII
About the author

- Earnings Miss: 22nd Century Group reported a Q1 GAAP EPS of -$5.07, missing expectations by $3.87, indicating significant challenges in profitability that could undermine investor confidence.
- Revenue Decline: The company generated $4.11 million in revenue for Q1, a 31% year-over-year decrease that fell short of the $4.6 million forecast, reflecting poor market performance and potential liquidity issues ahead.
- Stock Reaction: Following the earnings report, shares of 22nd Century dropped 18% in after-hours trading, signaling heightened investor concerns about the company's growth prospects, which may impact its financing capabilities and competitive position.
- Future Strategy: Despite the disappointing earnings, 22nd Century plans to launch Pinnacle Pure in 2026 and double its store count, demonstrating a long-term strategic intent to expand in the VLN market; however, short-term financial pressures may hinder execution capabilities.
- Financial Performance: Century Group Inc. reported earnings per share (EPS) of $5.07 for the first quarter.
- Market Context: The EPS figure reflects the company's performance amidst current market conditions.

- Revenue Growth: Century Group Inc. reported a net revenue increase to $4.1 million, up from $3.5 million.
- Financial Performance: The significant rise in revenue indicates a positive trend in the company's financial performance for the quarter.
- Earnings Announcement Schedule: 22nd Century is set to release its Q1 2023 earnings report on May 7 before market open, with consensus EPS estimate at -$1.20 and revenue expected at $4.61 million, reflecting a 22.7% year-over-year decline, indicating significant profitability challenges ahead.
- Historical Performance Review: Over the past two years, 22nd Century has failed to meet EPS estimates 100% of the time, although it has surpassed revenue expectations 75% of the time, highlighting a relative strength in revenue management but a pressing need for improvement in profitability.
- Market Reaction Analysis: The company's reduced nicotine strategy has not gained investor confidence, leading to poor stock performance, which may impact its future financing capabilities and market expansion plans.
- Future Strategic Planning: 22nd Century aims to double its store count and launch the Pinnacle Pure product by 2026 to drive VLN market expansion; if successful, this strategy could enhance market share and brand influence.
- Market Opportunity: With approximately 28 million smokers in the U.S. and 70% wanting to quit, 22nd Century Group's VLN® cigarettes, containing 95% less nicotine, cater to this demand for healthier options, potentially driving significant sales growth.
- Product Innovation: The VLN® cigarette is the only FDA-authorized low-nicotine combustible cigarette, proven to help smokers reduce nicotine intake after 28 years of research, establishing the company as a leader in tobacco harm reduction.
- Marketing Expansion: In 2026, the company plans to increase its retail footprint and enhance sales density in existing markets, which is expected to significantly boost awareness of VLN® products and help carve out new market niches in the competitive tobacco industry.
- Long-term Value Creation: The company is committed to driving long-term shareholder value through a diversified low-nicotine product portfolio and strong distribution networks, ensuring all stakeholders understand the importance of its technology in transforming smoking and nicotine addiction.
- Prototype Completion: 22nd Century Group has completed the product prototyping and initial analytical evaluations for its 100mm VLN cigarette, aiming to advance the regulatory process, although market reactions have been lukewarm, resulting in a significant stock price drop on Tuesday.
- Diverse Product Applications: The company intends to pursue multiple Premarket Tobacco Product Applications (PMTA) across a broad range of combustible products to support diverse tobacco blends and components, aiming to create a flexible and scalable platform to meet evolving market demands.
- Market Challenges Intensify: With the percentage of smokers declining to a record low of 9.9% in 2024, 22nd Century Group faces ongoing market challenges, and despite its efforts to develop lower nicotine cigarettes, investor confidence remains low, leading to continued stock price declines.
- Financial Concerns: The company acknowledged in its annual report a history of ongoing losses and warned of significant expenses and continued losses in the future, raising substantial doubt about its ability to continue as a going concern.








